EP3925956
1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
1.2.2017:
10.4.2024:
21173901.6
:
31.1.2037
:
1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS FACTOR D INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ABERRANT COMPLEMENT SYSTEM ACTIVITY, SUCH AS E.G. IMMUNOLOGICAL DISORDERS
1.2.2017
10.4.2024
:
BioCryst Pharmaceuticals, Inc.:
4505 Emperor Blvd., Durham, NC 27703, US
:
KOTIAN, Pravin, L:
Hoover, AL 35226, US
:
BABU, Yarlagadda, S.:
Birmingham, AL 35244, US
:
ZHANG, Weihe:
Vestavia, AL 35226, US
:
VOGETI, Lakshminarayana:
Lawrence, KS 66049, US
:
WU, Minwan:
Vestavia Hills, AL 35226, US
:
CHINTAREDDY, Venkat, R.:
Vestavia Hills, AL 35216, US
:
RAMAN, Krishnan:
Birmingham, AL 35244, US
:
201662289653 P:
1.2.2016:
US
:
C07D 401/12, C07D 231/56, C07D 209/40, C07D 209/48, C07D 487/04, C07D 471/04, C07D 403/12, C07D 403/04, C07D 403/06, C07D 401/14, C07D 401/04, C07D 401/06, C07D 405/12, C07D 209/12, C07D 209/42, A61K 31/416, A61P 37/00, A61P 37/06, A61P 25/00, A61P 21/04, A61K 31/4439, A61K 31/404, A61P 13/00, A61K 31/4035, A61P 13/12, A61P 25/28, A61P 9/00